Wuhan Back In Spotlight As Delta Variant Highlights Booster Shots Urgency
Delta Variant Poses New Challenges To China
Amid surging infections in several cities including Wuhan, China is urging vaccination among unvaccinated people, but a booster shot may be needed soon to address a low efficacy among Chinese vaccines, some say.
You may also be interested in...
Antibody COVID-19 Therapies Back in China Spotlight Amid Infection Surge
Chinese developers forge ahead with research into antibody therapies for COVID-19 as coronavirus variants gain a toe-hold in the country.
Big Pharma CEOs Suggest Policy Changes As They Return To Beijing
Global CEOs of J&J, Pfizer, AbbVie and Takeda were among the top pharma executives attending the China Development Forum in its first in-person meeting in three years, and highlighted a number of pharma-related policy changes they would like to see in China. Meanwhile, a Japanese employee of Astellas has been detained in the country for alleged espionage.
Chinese Biopharma Tycoons Down But Not Out In Latest Global Billionaire Ranking
China continues to dominate the latest list of global billionaires and top execs from domestic pharma firms Hengrui and Hansoh ranked among the wealthiest overall in the country, along with the founder of vaccine maker Zhifei Bio. A number of top Chinese biopharma business executives also featured in the global top 100 billionaires list.